Source: ACS Pharmacolology and Translational Science. Unidades: ICB, FM, IQ
Subjects: COVID-19, REPLICAÇÃO VIRAL, SAIS, MICROBIOLOGIA, CÉLULAS EPITELIAIS, CORONAVIRUS, SÍNDROME CORONARIANA AGUDA, DOENÇAS RESPIRATÓRIAS, MEMBRANA PLASMÁTICA
ABNT
MACHADO, Rafael Rahal Guaragna et al. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells. ACS Pharmacolology and Translational Science, v. 4, n. 5, p. 1514–1527, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsptsci.1c00080. Acesso em: 07 out. 2024.APA
Machado, R. R. G., Glaser, T., Araujo, D. B., Petiz, L. L., Durigon, D. B. L. de O., Durigon, G. S., et al. (2021). Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells. ACS Pharmacolology and Translational Science, 4( 5), 1514–1527. doi:10.1021/acsptsci.1c00080NLM
Machado RRG, Glaser T, Araujo DB, Petiz LL, Durigon DBL de O, Durigon GS, Leal AL, Pinho JRR, Ferreira LC de S, Ulrich H, Durigon EL, Carvalho CRG. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells [Internet]. ACS Pharmacolology and Translational Science. 2021 ; 4( 5): 1514–1527.[citado 2024 out. 07 ] Available from: https://doi.org/10.1021/acsptsci.1c00080Vancouver
Machado RRG, Glaser T, Araujo DB, Petiz LL, Durigon DBL de O, Durigon GS, Leal AL, Pinho JRR, Ferreira LC de S, Ulrich H, Durigon EL, Carvalho CRG. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells [Internet]. ACS Pharmacolology and Translational Science. 2021 ; 4( 5): 1514–1527.[citado 2024 out. 07 ] Available from: https://doi.org/10.1021/acsptsci.1c00080